Evidence map›Paper›PMID 33045255›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2021

Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria.

Shreeram Akilesh, Cynthia C Nast, Michifumi Yamashita, Kammi Henriksen, Vivek Charu, Megan L Troxell, Neeraja Kambham, Erika Bracamonte, Donald Houghton, Naila I Ahmed and 16 more

Abstract readMulticenter Study
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Long COVID and the kidney.Nature reviews. Nephrology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. An Update on Viral Infection-Associated Collapsing Glomerulopathy.Advances in kidney disease and health · 2024
    Review
  14. Collapsing Glomerulopathy.Advances in kidney disease and health · 2024
    Review
  15. The relation between proteinuria and the severity of COVID-19.Clinical and experimental nephrology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Shreeram AkileshDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA. Electronic address: shreeram@uw.edu.
Cynthia C NastDepartment of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA.
Michifumi YamashitaDepartment of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA.
Kammi HenriksenDepartment of Pathology, University of Chicago, Chicago, IL.
Vivek CharuDepartment of Pathology, Stanford University, Stanford, CA.
Megan L TroxellDepartment of Pathology, Stanford University, Stanford, CA.
Neeraja KambhamDepartment of Pathology, Stanford University, Stanford, CA.
Erika BracamonteDepartment of Pathology, University of Arizona, Tucson, AZ.
Donald HoughtonDepartment of Pathology, Oregon Health & Science University, Portland, OR.
Naila I AhmedNortheast Nephrology Consultants, Joliet, IL.
Chyi Chyi ChongDivision of Nephrology, Department of Medicine, University of Arizona, Tucson, AZ.
Bijin ThajudeenDivision of Nephrology, Department of Medicine, University of Arizona, Tucson, AZ.
Shehzad RehmanDivision of Nephrology Department of Medicine, Oregon Health & Science University, Portland, OR.
Firas KhouryOregon Kidney & Hypertension Clinic, Portland, OR.
Jonathan E ZuckermanDepartment of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA.
Jeremy GitomerProvidence Alaska Medical Center, Anchorage, AK.
Parthassarathy C RaguramCHI Franciscan Nephrology Associates, Tacoma, WA.
Shanza MujeebCHI Franciscan Nephrology Associates, Tacoma, WA.
Ulrike SchwarzeDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
M Brendan ShannonDivision of Nephrology, Department of Medicine, University of Washington, Seattle, WA.
Iris De CastroDivision of Nephrology, Department of Medicine, University of Washington, Seattle, WA.
Charles E AlpersDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
Behzad NajafianDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
Roberto F NicosiaDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
Nicole K AndeenDepartment of Pathology, Oregon Health & Science University, Portland, OR. Electronic address: andeen@ohsu.edu.
Kelly D SmithDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA. Electronic address: kelsmith@uw.edu.

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
The Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1M
NCATS NIH HHS KL2 TR001882NIDDK NIH HHS P30 DK017047
6 · The paper itself

Abstract

RATIONALE &

objectiveKidney biopsy data inform us about pathologic processes associated with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a multicenter evaluation of kidney biopsy findings in living patients to identify various kidney disease pathology findings in patients with coronavirus disease 2019 (COVID-19) and their association with SARS-CoV-2 infection. STUDY

designCase series. SETTING &

participantsWe identified 14 native and 3 transplant kidney biopsies performed for cause in patients with documented recent or concurrent SARS-CoV-2 infection treated at 7 large hospital systems in the United States. OBSERVATIONS: Men and women were equally represented in this case series, with a higher proportion of Black (n=8) and Hispanic (n=5) patients. All 17 patients had SARS-CoV-2 infection confirmed by reverse transcriptase-polymerase chain reaction, but only 3 presented with severe COVID-19 symptoms. Acute kidney injury (n=15) and proteinuria (n=11) were the most common indications for biopsy and these symptoms developed concurrently or within 1 week of COVID-19 symptoms in all patients. Acute tubular injury (n=14), collapsing glomerulopathy (n=7), and endothelial injury/thrombotic microangiopathy (n=6) were the most common histologic findings. 2 of the 3 transplant recipients developed active antibody-mediated rejection weeks after COVID-19. 8 patients required dialysis, but others improved with conservative management. LIMITATIONS: Small study size and short clinical follow-up.

conclusionsCases of even symptomatically mild COVID-19 were accompanied by acute kidney injury and/or heavy proteinuria that prompted a diagnostic kidney biopsy. Although acute tubular injury was seen among most of them, uncommon pathology such as collapsing glomerulopathy and acute endothelial injury were detected, and most of these patients progressed to irreversible kidney injury and dialysis.

Indexed as

Acute Kidney InjuryAdultAgedCOVID-19Diagnosis, DifferentialFemaleFollow-Up StudiesHumansKidneyMaleMiddle AgedProteinuriaacute kidney injury (AKI)allograft biopsyantibody-mediated rejection (AMR)case seriescollapsing glomerulopathyCoronavirus disease 2019 (COVID-19)kidney biopsyrenal complications of COVID-19renal pathologysevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)thrombotic microangiopathy

Identifiers

PMID33045255
PMCPMC7546949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.